Cannabis for Pain: CBD & Beta-caryophyllene for Chronic Pain
Updated: Apr 24
Welcome to homework assignment CPS 1.10 in the Cannabis for Pain seminar from Higher Learning LV. This seminar provides a review of recently published peer-reviewed scientific research on the topic of the potential medicinal efficacy of cannabis for pain. This assignment in particular focuses on a study published in 2023 about the potential efficacy of the cannabinoid CBD and the terpene beta-caryophyllene to reduce chronic pain resulting from spinal cord injury.
When you complete this homework assignment, simply click the link at the bottom of the article to return to the master page for this seminar.
A 2023 study entitled "Combined Non-psychoactive Cannabis Components Cannabidiol and β-caryophyllene Reduce Chronic Pain via CB1 Interaction in a Rat Spinal Cord Injury Model" that was published in the journal PLOS ONE had the goal of assessing the potential of cannabis cannabinoids to reduce neuropathic pain resulting from spinal cord injury (SCI).
Want to read more?
Subscribe to www.higherlearninglv.co to keep reading this exclusive post.
Subscribe Now